amantadine has been researched along with Ambulation Disorders, Neurologic in 12 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "In advanced Parkinson's disease (PD), axial symptoms such as speech, gait, and balance impairment often become levodopa-unresponsive and they are difficult to manage, even in patients with subthalamic nucleus deep brain stimulation (STN-DBS)." | 2.78 | Amantadine improves gait in PD patients with STN stimulation. ( Chan, HF; Kukkle, PL; Lim, SY; Merello, M; Moro, E; Poon, YY, 2013) |
| "Levodopa is the most effective medical treatment for Parkinson disease." | 1.38 | Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease. ( Tarsy, D, 2012) |
| "Treatment included induction of coma while a native immune response matured; rabies vaccine was not administered." | 1.33 | Survival after treatment of rabies with induction of coma. ( Amlie-Lefond, CM; Chusid, MJ; Ghanayem, NS; Hoffman, GM; Rupprecht, CE; Schwabe, MJ; Tieves, KS; Willoughby, RE, 2005) |
| "It is mainly related to disease progression and levodopa treatment." | 1.31 | Freezing of gait in patients with advanced Parkinson's disease. ( Giladi, N; Kandinov, B; Korczyn, AD; Orlov, Y; Paleacu, D; Shabtai, H; Simon, ES; Treves, TA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Shorafat, DM | 1 |
| Lang, AE | 1 |
| McGarry, A | 1 |
| Biglan, K | 1 |
| Lee, JY | 1 |
| Oh, S | 1 |
| Kim, JM | 1 |
| Kim, JS | 2 |
| Oh, E | 1 |
| Kim, HT | 1 |
| Jeon, BS | 2 |
| Cho, JW | 1 |
| Zhang, LL | 1 |
| Canning, SD | 1 |
| Wang, XP | 1 |
| Kim, YE | 1 |
| Yun, JY | 1 |
| Tarsy, D | 1 |
| Chan, HF | 1 |
| Kukkle, PL | 1 |
| Merello, M | 1 |
| Lim, SY | 1 |
| Poon, YY | 1 |
| Moro, E | 1 |
| Takahashi, H | 1 |
| Shinohara, Y | 1 |
| Willoughby, RE | 1 |
| Tieves, KS | 1 |
| Hoffman, GM | 1 |
| Ghanayem, NS | 1 |
| Amlie-Lefond, CM | 1 |
| Schwabe, MJ | 1 |
| Chusid, MJ | 1 |
| Rupprecht, CE | 1 |
| Giladi, N | 1 |
| Treves, TA | 1 |
| Simon, ES | 1 |
| Shabtai, H | 1 |
| Orlov, Y | 1 |
| Kandinov, B | 1 |
| Paleacu, D | 1 |
| Korczyn, AD | 1 |
| Baezner, H | 1 |
| Oster, M | 1 |
| Henning, O | 1 |
| Cohen, S | 1 |
| Hennerici, MG | 1 |
| Lee, KJ | 1 |
| Guak, TH | 1 |
| Kim, BS | 1 |
| Yang, DW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Experimentally-induced Freezing of Gait in Parkinson's Disease by Modulating Step Length/Asymmetry and Cognitive/Visual Loading[NCT04799613] | 20 participants (Anticipated) | Interventional | 2021-03-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amantadine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Freezing of Gait in Parkinsonism and its Potential Drug Treatment.
Topics: Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Botulinum Toxins; Droxidopa; Gait Disorde | 2016 |
[Diagnosis and therapy for patients with vascular parkinsonism].
Topics: Akinetic Mutism; Amantadine; Antiparkinson Agents; Cerebral Infarction; Dementia, Vascular; Diagnosi | 2003 |
4 trials available for amantadine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Intravenous amantadine on freezing of gait in Parkinson's disease: a randomized controlled trial.
Topics: Aged; Amantadine; Antiparkinson Agents; Double-Blind Method; Gait; Gait Disorders, Neurologic; Human | 2013 |
Effect of intravenous amantadine on dopaminergic-drug-resistant freezing of gait.
Topics: Aged; Amantadine; Antiparkinson Agents; Gait Disorders, Neurologic; Humans; Infusions, Intravenous; | 2011 |
Amantadine improves gait in PD patients with STN stimulation.
Topics: Adult; Amantadine; Antiparkinson Agents; Combined Modality Therapy; Deep Brain Stimulation; Female; | 2013 |
Amantadine increases gait steadiness in frontal gait disorder due to subcortical vascular encephalopathy: a double-blind randomized placebo-controlled trial based on quantitative gait analysis.
Topics: Amantadine; Antiparkinson Agents; Brain; Dementia, Vascular; Double-Blind Method; Gait; Gait Disorde | 2001 |
6 other studies available for amantadine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.
Topics: Adolescent; Amantadine; Dopamine Agents; Female; Gait; Gait Disorders, Neurologic; Humans; Male; Pan | 2019 |
Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and Parkinsonism.
Topics: Aged; Amantadine; Antiparkinson Agents; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; H | 2013 |
Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease.
Topics: Amantadine; Antiparasitic Agents; Carbidopa; Catechols; Decision Making; Deep Brain Stimulation; Dis | 2012 |
Survival after treatment of rabies with induction of coma.
Topics: Adolescent; Amantadine; Anesthetics; Animals; Antiviral Agents; Athetosis; Benzodiazepines; Bites an | 2005 |
Freezing of gait in patients with advanced Parkinson's disease.
Topics: Adult; Age of Onset; Amantadine; Antiparkinson Agents; Disease Progression; Dopamine Agonists; Femal | 2001 |
Gait ignition failure after unilateral anteromedial pallidotomy.
Topics: Amantadine; Dopamine Agents; Female; Functional Laterality; Gait Disorders, Neurologic; Globus Palli | 2001 |